SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-304570
Filing Date
2011-11-09
Accepted
2011-11-09 16:14:01
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d233403d10q.htm 10-Q 578554
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) d233403dex311.htm EX-31.1 6172
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) d233403dex312.htm EX-31.2 6217
4 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER d233403dex321.htm EX-32.1 4021
  Complete submission text file 0001193125-11-304570.txt   1742693

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdvn-20110930.xml EX-101.INS 216714
6 XBRL TAXONOMY EXTENSION SCHEMA mdvn-20110930.xsd EX-101.SCH 13807
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdvn-20110930_cal.xml EX-101.CAL 29200
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdvn-20110930_lab.xml EX-101.LAB 98980
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdvn-20110930_pre.xml EX-101.PRE 64377
Mailing Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105
Business Address 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO CA 94105 415-543-3470
MEDIVATION, INC. (Filer) CIK: 0001011835 (see all company filings)

IRS No.: 133863260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32836 | Film No.: 111191842
SIC: 2834 Pharmaceutical Preparations